---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293358548.md"
description: "Trevi Therapeutics shares are trading higher after BMO Capital initiated its coverage on the stock with an Outperform rating and announced a price target of $36."
datetime: "2026-07-21T14:32:39.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293358548.md)
  - [en](https://longbridge.com/en/news/293358548.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293358548.md)
generator: "portal-rs"
---

# 

Trevi Therapeutics shares are trading higher after BMO Capital initiated its coverage on the stock with an Outperform rating and announced a price target of $36.

### Related Stocks

- [TRVI.US](https://longbridge.com/en/quote/TRVI.US.md)
- [BMO.US](https://longbridge.com/en/quote/BMO.US.md)

## Related News & Research

- [Trevi Therapeutics to present Phase 2b CORAL nalbuphine ER quality-of-life data in IPF cough at ERS 2026](https://longbridge.com/en/news/297037112.md)
- [Trevi Therapeutics, Inc. (NASDAQ:TRVI) Receives Consensus Recommendation of "Buy" from Analysts](https://longbridge.com/en/news/296880224.md)
- [BMO Completes Sale of 138 U.S. Branches to First Citizens Bank | BMO Stock News](https://longbridge.com/en/news/298078907.md)
- [BMO Capital Sticks to Its Buy Rating for FireFly Metals (FFMFF)](https://longbridge.com/en/news/298033270.md)
- [Trevi Therapeutics Initiated at Buy on Clean Late-Stage Execution, De-Risked IPF Cough and RCC Pipelines, and Solid Cash Position](https://longbridge.com/en/news/295837729.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**